Phase 2 HER2 Negative Breast Carcinoma trials recruiting now

All HER2 Negative Breast Carcinoma trials, every phase

Other phases for HER2 Negative Breast Carcinoma

Phase 2 HER2 Negative Breast Carcinoma trials

• A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
  NCT07483307 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 7 locations
• DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
  NCT06176261 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
  NCT06042569 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 3 locations
• Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
  NCT06026657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
  NCT07276880 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
  NCT06450873 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.